Brian C. VanderVen
Impact in
- Infectious Diseases top 1%
- Tuberculosis Research and Epidemiology
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
Papers in
-
- Tuberculosis Research and Epidemiology 25
-
- Antibiotic Resistance in Bacteria 5
- Co-authors
- David G. RussellLu HuangWonsik LeeJohn T. BelisleKaley M. WilburnDean C. CrickRobin M. YatesRobert B. Abramovitch
- Journals
- Molecular Microbiology (4 papers)Journal of Biological Chemistry (4 papers)eLife (3 papers)Nature reviews. Immunology (2 papers)Scientific Reports (2 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Brian C. VanderVen
36 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 112
- Infectious Diseases 1.2k
- Molecular Medicine 239
- Immunology 564
- Epidemiology 921
- Pharmacology 175
Countries citing papers authored by Brian C. VanderVen
This map shows the geographic impact of Brian C. VanderVen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian C. VanderVen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian C. VanderVen more than expected).
Fields of papers citing papers by Brian C. VanderVen
This network shows the impact of papers produced by Brian C. VanderVen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian C. VanderVen. The network helps show where Brian C. VanderVen may publish in the future.
Co-authors
The 25 scholars most cited alongside Brian C. VanderVen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2023 | 14 | |
| 3 | 2023 | 18 | |
| 4 | 2023 | 4 | |
| 5 | 2022 | 17 | |
| 6 | 2022 | 16 | |
| 7 | 2021 | 12 | |
| 8 | 2021 | 10 | |
| 9 | 2019 | 49 | |
| 10 | 2019 | 334 | |
| 11 | 2018 | 4 | |
| 12 | 2017 | 18 | |
| 13 | 2017 | 55 | |
| 14 | 2017 | 125 | |
| 15 | 2015 | 91 | |
| 16 | 2015 | 203 | |
| 17 | 2013 | 299 | |
| 18 | 2010 | 143 | |
| 19 | 2009 | 140 | |
| 20 | 2005 | 244 |
About Brian C. VanderVen
Brian C. VanderVen is a scholar working on Infectious Diseases, Molecular Medicine, Pharmacology, Epidemiology and Neurology, having authored 36 papers that have together received 2.5k indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (25 papers), Mycobacterium research and diagnosis (13 papers), Biochemical and Molecular Research (10 papers), Antibiotic Resistance in Bacteria (5 papers), Pharmacogenetics and Drug Metabolism (4 papers), Diagnosis and treatment of tuberculosis (4 papers), Immune Response and Inflammation (4 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers). The work is most often cited by research in Infectious Diseases (1.2k citations), Molecular Medicine (239 citations), Immunology (564 citations), Epidemiology (921 citations) and Pharmacology (175 citations). Brian C. VanderVen has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include David G. Russell, Lu Huang, Wonsik Lee, John T. Belisle, Kaley M. Wilburn, Dean C. Crick, Wonsik Lee, Robin M. Yates, Robert B. Abramovitch and Kyle H. Rohde. Their work appears in journals such as Molecular Microbiology, Journal of Biological Chemistry, eLife, Nature reviews. Immunology and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.